Addition TherapeuticsListed
additiontx.combiotech_life_sciences
Addition Therapeutics is advancing a pipeline of therapeutics to deliver functional cures for patients with severe lifelong diseases in large and rare populations, leveraging its…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Addition Therapeutics is advancing a pipeline of therapeutics to deliver functional cures for patients with severe lifelong diseases in large and rare populations, leveraging its…
Biotechnology company developing precision genetic therapies intended to restore, improve, and preserve hearing, including treatments targeting hearing loss through inner-ear gene…
Clinical-stage biotechnology company developing therapies for liver and viral diseases, including chronic hepatitis B, MASH, and coronaviruses. Its pipeline includes an oral small…
A Grifols subsidiary and research and drug discovery company using plasma proteomics, AI, multiomics, and real-world data to identify disease biomarkers and develop potential plas…
Clinical-stage biopharmaceutical company developing genetically and pharmacologically validated therapies for cardiovascular and metabolic diseases. Its pipeline includes protein-…
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, addressing significant unmet needs in the…
Avalyn is a clinical-stage biotech company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
BioAge Labs is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging.
Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company is developing novel i…
Cybin Inc. is a clinical-stage neuropsychiatry company focused on revolutionizing mental healthcare through the development of next-generation treatment options, particularly util…
Engrail Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative, precision-targeted therapeutics for neuropsychiatric and neurodevelopmental disor…
Evommune is a clinical-stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases. The company's mission…
Exscientia is a pioneering AI-driven drug discovery company that utilizes advanced artificial intelligence and machine learning to enhance the efficiency and effectiveness of drug…
Fusion Pharmaceuticals is a biopharmaceutical company focused on developing targeted alpha-particle radiotherapeutics for treating cancer, utilizing proprietary technologies to li…
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development of its investigational drug product, seralutinib, for the treatment of pulmonary arterial hyp…
Clinical-stage biopharmaceutical company developing autologous and allogeneic cell therapies for cancer and autoimmune diseases. Its FasTCAR, TruUCAR, and SMART CART platforms aim…
Grail is a healthcare company focused on multi-cancer early detection through innovative genomic technologies, including the Galleri test, which can detect over 50 types of cancer…
Harmony Biosciences is focused on developing innovative treatments for rare neurological diseases, particularly in the areas of sleep/wake disorders and rare epilepsy syndromes.
HotSpot Therapeutics is pioneering a new approach to allosteric drug discovery by unlocking the on/off switches on proteins called 'natural hotspots' to enable differentiated medi…
Clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates, radioligand therapies, and a gamma secretase inhibitor. Its pipeline incl…
Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Their lead product candidate is INZ-701, an e…
Details are not available yet. The company remains listed.
Karuna Therapeutics is focused on developing first-in-class therapeutics for central nervous system disorders, particularly schizophrenia and Alzheimer's disease. Their lead produ…
LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric dise…
Private biotechnology company developing proprietary small-molecule therapies and diagnostic biomarkers for complex diseases, initially focused on CNS disorders. It uses knowledge…
A clinical-stage biopharma company based in California, focused on therapies for CNS disorders. The company employs proprietary technologies including optogenetics, STARmap and tr…
Mosanna is developing an easy-to-use nighttime nasal spray to help restore the body’s natural airway control for obstructive sleep apnea patients.
Obsidian Therapeutics is pioneering engineered TIL cell therapies using its proprietary cytoDRiVE® platform to improve outcomes for patients with solid tumor malignancies.
Oculis is a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology. It develops t…
Omniome is a biotechnology company developing a proprietary DNA sequencing platform capable of delivering high sequencing accuracy.
Parabilis is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important target…
Plexium is a biotechnology research company focused on targeted protein degradation (TPD). It develops small-molecule therapeutics, including monovalent direct degraders and molec…
Clinical-stage biotechnology company developing therapies for severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
Trevi Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing Haduvio (oral nalbuphine ER) to help patients suffering from chronic cough conditions, inc…
Twist Bioscience is a leader in DNA synthesis, providing innovative solutions for various applications including gene synthesis, oligo pools, and antibody discovery.
Vaxcyte is focused on developing innovative vaccines to address unmet medical needs in infectious diseases and cancer.
Biopharmaceutical company that develops, manufactures, and commercializes advanced cell therapies and specialty biologics for sports medicine and severe burn care. Its products in…
Vigil Neuroscience is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases by targeting microglial biology and neuroinflammation.
Zenas Biopharma is dedicated to developing transformative therapies for patients with autoimmune diseases, focusing on innovative drug development and commercialization.